Stay updated on Rapastinel Long-term Safety in Major Depressive Disorder Clinical Trial
Sign up to get notified when there's something new on the Rapastinel Long-term Safety in Major Depressive Disorder Clinical Trial page.

Latest updates to the Rapastinel Long-term Safety in Major Depressive Disorder Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedRevision updated from v3.4.1 to v3.4.2. No study data or user-facing content was changed.SummaryDifference0.0%

- Check17 days agoChange DetectedThe update shows a minor revision from v3.4.0 to v3.4.1 with no observable impact on study details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check32 days agoChange DetectedUI and metadata updates on the study page include a glossary display option and the addition of a 'Last Update Submitted that Met QC Criteria' field. These changes also remove the older 'No FEAR Act data' item and the prior revision (v3.3.4), replacing it with 'Revision: v3.4.0'.SummaryDifference0.1%

- Check39 days agoChange DetectedThe page now lists revision: v3.3.4, replacing the previous v3.3.3. This appears to be an internal version update with no impact on study details or data.SummaryDifference0.0%

- Check67 days agoChange DetectedA Locations section listing all site locations by state has been added, and the HHS Vulnerability Disclosure notice and per-state location blocks have been removed.SummaryDifference2%

- Check89 days agoChange DetectedThe page shows a revision update from v3.3.1 to v3.3.2, with no visible changes to the study details or layout. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Rapastinel Long-term Safety in Major Depressive Disorder Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Rapastinel Long-term Safety in Major Depressive Disorder Clinical Trial page.